Manulife (Manufacturers Life Insurance)’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-14,653
| Closed | -$68 | – | 3220 |
|
2021
Q4 | $68 | Sell |
14,653
-5,749
| -28% | -$27 | ﹤0.01% | 3081 |
|
2021
Q3 | $174K | Buy |
20,402
+1,915
| +10% | +$16.3K | ﹤0.01% | 3030 |
|
2021
Q2 | $303K | Buy |
18,487
+1,356
| +8% | +$22.2K | ﹤0.01% | 2804 |
|
2021
Q1 | $378K | Buy |
17,131
+1,526
| +10% | +$33.7K | ﹤0.01% | 2464 |
|
2020
Q4 | $483K | Buy |
15,605
+1,002
| +7% | +$31K | ﹤0.01% | 2220 |
|
2020
Q3 | $297K | Buy |
14,603
+3,959
| +37% | +$80.5K | ﹤0.01% | 2304 |
|
2020
Q2 | $166K | Buy |
+10,644
| New | +$166K | ﹤0.01% | 2580 |
|